KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Diluted Average) (2020 - 2026)

Medpace Holdings filings provide 7 years of Shares Outstanding (Diluted Average) readings, the most recent being $29.0 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 7.16% to $29.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $29.0 million, a 7.16% decrease, with the full-year FY2025 number at $29.5 million, down 7.77% from a year prior.
  • Shares Outstanding (Diluted Average) hit $29.0 million in Q1 2026 for Medpace Holdings, down from $29.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $36.4 million in Q1 2022 to a low of $28.8 million in Q3 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $32.0 million (2024), compared with a mean of $32.0 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): decreased 11.57% in 2023 and later grew 1.49% in 2024.
  • Medpace Holdings' Shares Outstanding (Diluted Average) stood at $33.7 million in 2022, then fell by 5.43% to $31.8 million in 2023, then increased by 0.54% to $32.0 million in 2024, then decreased by 7.77% to $29.5 million in 2025, then fell by 1.91% to $29.0 million in 2026.
  • The last three reported values for Shares Outstanding (Diluted Average) were $29.0 million (Q1 2026), $29.5 million (Q4 2025), and $28.8 million (Q3 2025) per Business Quant data.